QA: Intercept Pharmaceuticals INC in us_pharma/2020

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001270073_2021_Intercept_Pharmaceuticals_INC.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001270073, Intercept Pharmaceuticals INC

  xvar xval
0 AssetsCurrent 545,741,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 6,326,000
3 remainder_Assets 28,422,000
4 LiabilitiesCurrent 179,076,000
5 LiabilitiesNoncurrent 568,266,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 9,287,764
8 SellingGeneralAndAdministrativeExpense 342,375,237
9 ResearchAndDevelopmentExpense 180,255,674
10 remainder_Expenses 14,630,000
11 remainder_Revenues 480,377,304
12 remainder_NetIncome -50,640,369
13 remainder_ComprehensiveNetIncome 1,118,940
  yvar yval
0 Assets 580,489,000
1 Liabilities 747,342,000
2 Expenses 546,548,675
3 Revenues 480,377,304
4 StockholdersEquity -166,853,000
5 NetIncome -116,811,740
6 ComprehensiveNetIncome -116,252,270
7 BaseVar 1,203,258,144
8 EconomicCapitalRatiobeforeLimitedLiability -0.723
9 EconomicCapitalRatio 1.35

Edgar->Model Mapping

Feature Distribution

Change over Time